Sanford C. Bernstein Reiterates Market Perform Rating for HCA Holdings Inc. (HCA)
HCA Holdings Inc. (NYSE:HCA)‘s stock had its “market perform” rating reissued by stock analysts at Sanford C. Bernstein in a report released on Tuesday. They presently have a $85.00 target price on the stock, down from their previous target price of $89.00. Sanford C. Bernstein’s price objective would suggest a potential upside of 15.58% from the stock’s previous close.
HCA has been the subject of a number of other research reports. Zacks Investment Research upgraded HCA Holdings from a “hold” rating to a “buy” rating and set a $89.00 price objective for the company in a report on Tuesday, July 26th. Evercore ISI initiated coverage on HCA Holdings in a research report on Thursday, September 22nd. They set a “hold” rating and a $89.00 target price for the company. Avondale Partners lowered HCA Holdings from an “outperform” rating to a “market perform” rating in a research report on Wednesday, November 9th. Wolfe Research initiated coverage on HCA Holdings in a research report on Tuesday, October 25th. They set an “outperform” rating for the company. Finally, JPMorgan Chase & Co. lowered HCA Holdings from an “overweight” rating to a “neutral” rating and set a $85.00 target price for the company. in a research report on Friday, July 29th. Nine research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $87.30.
Shares of HCA Holdings (NYSE:HCA) opened at 73.54 on Tuesday. HCA Holdings has a 52-week low of $60.07 and a 52-week high of $83.69. The stock has a market capitalization of $27.55 billion, a PE ratio of 11.64 and a beta of 0.79. The company’s 50 day moving average price is $76.78 and its 200 day moving average price is $77.20.
HCA Holdings (NYSE:HCA) last posted its quarterly earnings data on Thursday, October 27th. The company reported $1.61 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.42 by $0.19. HCA Holdings had a negative return on equity of 43.65% and a net margin of 6.10%. The company earned $10.27 billion during the quarter, compared to analysts’ expectations of $10.41 billion. During the same quarter in the previous year, the business earned $1.17 EPS. HCA Holdings’s revenue was up 4.2% compared to the same quarter last year. On average, equities research analysts anticipate that HCA Holdings will post $6.71 EPS for the current year.
In other HCA Holdings news, insider A Bruce Moore, Jr. sold 167,967 shares of the stock in a transaction that occurred on Wednesday, November 9th. The stock was sold at an average price of $73.65, for a total transaction of $12,370,769.55. Following the transaction, the insider now owns 207,682 shares in the company, valued at $15,295,779.30. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Michael S. Cuffe sold 2,150 shares of the stock in a transaction that occurred on Friday, October 28th. The stock was sold at an average price of $79.41, for a total value of $170,731.50. The disclosure for this sale can be found here. 3.10% of the stock is owned by insiders.
Institutional investors have recently modified their holdings of the company. Howard Hughes Medical Institute acquired a new position in shares of HCA Holdings during the third quarter worth about $124,000. Acrospire Investment Management LLC increased its position in shares of HCA Holdings by 35.7% in the second quarter. Acrospire Investment Management LLC now owns 1,900 shares of the company’s stock worth $146,000 after buying an additional 500 shares in the last quarter. First Mercantile Trust Co. acquired a new position in shares of HCA Holdings during the third quarter worth about $147,000. HL Financial Services LLC acquired a new position in shares of HCA Holdings during the third quarter worth about $201,000. Finally, Raymond James Trust N.A. acquired a new position in shares of HCA Holdings during the third quarter worth about $202,000. Institutional investors own 71.43% of the company’s stock.
HCA Holdings Company Profile
HCA Holdings, Inc is a healthcare services company. The Company’s segment is operating hospitals and related healthcare entities. The Company operates approximately 168 hospitals, consisting of 164 general, acute care hospitals; three psychiatric hospitals, and one rehabilitation hospital. In addition, the Company operates approximately 116 freestanding surgery centers.
Receive News & Stock Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related stocks with our FREE daily email newsletter.